U.S. Energy Services Stock News

RealReal (REAL) just wrapped up FY 2025 with fourth quarter revenue of US$194.1 million and a basic EPS loss of US$0.33, alongside trailing twelve month revenue of US$692.8 million and a basic EPS loss of US$0.36. Over recent quarters, the company has seen revenue range from US$147.8 million in Q3 2024 to US$194.1 million in Q4 2025, while quarterly EPS has swung between a loss of US$0.62 in Q4 2024 and a profit of US$0.56 in Q1 2025. This backdrop is likely to encourage investors to focus...

Minerals Technologies Inc. recently reported first-quarter 2026 results, with sales rising to US$546.9 million from US$491.8 million a year earlier and net income improving to US$36.2 million from a US$144 million loss. The swing from a basic loss per share from continuing operations of US$4.51 to earnings of US$1.17 highlights a sharp turnaround in profitability that may reframe how investors view the company’s earnings power. We’ll now explore how this sharp earnings turnaround, alongside...

Inter & Co (INTR) just posted its first quarter 2026 results, reporting net income of R$394.79 million and basic earnings per share from continuing operations of R$0.89. The company also provided updates on client growth and digital initiatives. See our latest analysis for Inter & Co. Even with record Q1 profitability, a new AI tool in Seven and refreshed corporate bylaws, momentum in the stock has cooled, with a 30 day share price return of 13.55% decline and a 1 year total shareholder...

Opendoor Technologies (OPEN) has become a focus for investors after announcing adjusted EBITDA profitability on a 12 month forward basis from April 1, alongside better resale margins, quicker inventory turnover, and tighter cost control. See our latest analysis for Opendoor Technologies. That profitability milestone comes after a volatile stretch where the stock has a 30 day share price return of 16.92% but a year to date share price return of a 12.36% decline, alongside a very large 1 year...

The Sherwin-Williams Company recently reported first-quarter 2026 results showing higher sales of US$5,666.9 million and increased net income of US$534.7 million versus a year earlier, while also completing a long-running share repurchase program totaling 106.98 million shares for about US$16.58 billion. The company paired this earnings improvement with reaffirmed full-year 2026 guidance and continued logistics efficiencies, suggesting management confidence in its operating plans and cost...

Babcock & Wilcox Enterprises, Inc. recently secured more than US$21,000,000 in U.S. awards for coal-to-gas fuel switching technologies, building on over 150 prior boiler conversions and a 100 MW project completed ahead of schedule and on budget in 2025. At the same time, multiple law firms have launched securities class actions alleging misleading disclosures and undisclosed conflicts around a multibillion-dollar power generation contract, putting the company’s governance and contract...

Why National Bank Holdings Stock Is On Investors’ Radar Today National Bank Holdings (NBHC) has drawn attention after recent trading data highlighted a market value of about $1.9b and a last close of $42.81, prompting fresh interest in its valuation and fundamentals. See our latest analysis for National Bank Holdings. While the 1-day share price return of -0.35% may catch the eye, the 30-day share price return of 6.70%, year-to-date share price return of 12.96%, and 1-year total shareholder...

Key recent performance context IHS Holding (NYSE:IHS) has drawn investor attention after recent trading that left the stock near US$8.23, with year to date total return of about 12% and 1 year total return around 44%. Over the past month, the stock’s return has been slightly negative, while the past 3 months show a small positive move. This gives investors a mixed short term picture alongside stronger longer term performance. See our latest analysis for IHS Holding. For you as a shareholder,...

Innospec (IOSP) has wrapped up FY 2025 with fourth quarter revenue of US$455.6 million and basic EPS of US$1.91, alongside full year trailing EPS of US$4.69 on revenue of US$1.78 billion that reflects a very large year on year earnings pickup. Over recent quarters the company has seen revenue move from US$466.8 million in Q4 2024 to US$455.6 million in Q4 2025. Basic EPS shifted from a loss of US$2.82 to a profit of US$1.91, setting the stage for investors to focus on how the higher 6.6% net...

If you are wondering whether Apollo Global Management's current share price lines up with its underlying worth, this article walks through the key numbers in plain language. The stock last closed at US$127.79, with a 21.3% gain over the past 30 days, a 0.7% decline over 7 days, a 12.8% decline year to date and a 2.6% decline over the past year. This is set against a 110.8% return over 3 years and a 152.8% return over 5 years. Recent attention on Apollo Global Management has focused on how...

COPT Defense Properties recently reported past first-quarter 2026 results, with revenue rising to US$200.64 million and net income to US$38.56 million, alongside diluted EPS of US$0.34 from continuing operations. Alongside these results, management raised full-year 2026 diluted EPS guidance to US$1.24–US$1.30 and set second-quarter guidance at US$0.31–US$0.33, signaling confidence in the company’s operating outlook. Next, we’ll examine how this higher full-year earnings guidance could...

Recent performance snapshot Box (BOX) has drawn attention after a recent move in its share price, with the stock up about 6% over the past week and around 7% over the past month. See our latest analysis for Box. The recent 1 day share price return of 5.98% and 7 day return of 6.16% sit against a year-to-date share price decline of 10.89%, while the 1 year total shareholder return is down 18.16%. This points to short-term momentum following a weaker period. If this move in Box has you thinking...

What the recent move in BrightSpring Health Services (BTSG) means for investors BrightSpring Health Services (BTSG) has recently drawn attention after a strong run in the stock over the past month and past 3 months, prompting investors to reassess how its current valuation lines up with its fundamentals. See our latest analysis for BrightSpring Health Services. The recent strength in BrightSpring Health Services’ stock, with a 30 day share price return of 20.67% and a 90 day share price...

Why Warrior Met Coal is on investors’ radar Warrior Met Coal (HCC) has drawn attention after a 1 day gain of 0.34% contrasted with a month return of 5.56% and a past 3 months return of 1.36%. That short term pattern, together with a 1 year total return of 94.76% and multi year total returns reaching very large multiples of the starting point, has many investors reassessing where the stock currently sits. See our latest analysis for Warrior Met Coal. With the share price at $87.84, Warrior Met...

Halper Sadeh LLC is investigating e.l.f. Beauty (NYSE:ELF) for potential breaches of fiduciary duty by the company’s officers and directors. The review focuses on whether the board’s decisions have been consistent with obligations to shareholders and could have implications for corporate governance and oversight. The investigation may result in calls for board or policy changes, or potential financial relief, depending on its findings. e.l.f. Beauty operates in the color cosmetics and...

Masimo shareholders have officially approved the merger with Danaher (NYSE:DHR). The vote clears a key milestone for the acquisition and allows the deal process to move toward closing. The transaction is expected to expand Danaher's presence in diagnostics and medical technology once remaining conditions are met. For investors watching NYSE:DHR, this approval matters because it comes at a time when diagnostics, patient monitoring and broader medical technology are central to hospital and...

If you are trying to figure out whether Apellis Pharmaceuticals is attractively priced today, it helps to start with how the current market value lines up against different ways of estimating fair value. The stock last closed at US$41.01, with returns of 0.1% over 7 days, 0.8% over 30 days, 58.6% year to date and 130.3% over the past year, alongside 3 year and 5 year returns of 53.7% decline and 10.1% decline respectively. This gives a mixed picture for anyone thinking about entry or exit...

In late April 2026, Porch Group, Inc. reported first-quarter results showing sales of US$121.12 million, up from US$104.75 million a year earlier, while moving from net income of US$8.40 million to a net loss of US$4.71 million. At the same time, Porch Group shifted from earnings per share of US$0.08 to a loss of US$0.04, and followed up with non-deal roadshow presentations in Boston and New York to explain its evolving business model to investors. With first-quarter revenue growth...

Recent performance snapshot for Federal Home Loan Mortgage Federal Home Loan Mortgage (FMCC) has drawn attention after a 1-month return of about 26%, contrasting with a year-to-date decline of roughly 31% and a 3-month decline of nearly 3%. See our latest analysis for Federal Home Loan Mortgage. The share price has recently swung higher, with a 30 day share price return of about 26% from a last close of US$7.14. However, this follows a weaker year to date share price return and contrasts with...

Vistra (VST) has wrapped up FY 2025 with fourth quarter revenue of US$4.6b, Basic EPS of US$0.55 and net income of US$185m, rounding out a trailing twelve month picture that totals US$17.7b in revenue, Basic EPS of US$2.22 and net income of US$752m. Over recent quarters, reported revenue has moved from US$4.0b in Q4 2024 to US$4.6b in Q4 2025, while quarterly Basic EPS has ranged from US$1.16 in Q4 2024 to US$0.55 most recently, setting up a results season where investors are weighing...

Earlier this week, enGene Therapeutics reported interim Phase 2 LEGEND trial results for its bladder cancer gene therapy detalimogene voraplasmid, revealing a 54% complete response rate but weaker 12‑month durability than previously expected, alongside generally manageable side effects and low disease progression. The mixed efficacy profile has triggered analyst downgrades and shareholder-rights investigations, highlighting how a single data update can rapidly reshape perceptions of a...

Why Enpro's updated 2026 guidance is on investors’ radar Enpro (NPO) raised its full-year 2026 revenue growth guidance to a range of 10% to 14% after reporting first-quarter sales of US$303 million and net income of US$27.4 million, both above last year. See our latest analysis for Enpro. Following the upgraded 2026 outlook, the stock has had a strong run, with a 30 day share price return of 18.13% and a year to date share price return of 37.20%. The 1 year total shareholder return of 67.81%...

Earlier this week, Teradata Corporation reported Q1 2026 results with revenue of US$444 million and GAAP diluted EPS of US$3.47, lifted by a very large US$480 million settlement from SAP and solid recurring revenue growth. Teradata also unveiled its new Autonomous Knowledge Platform, aiming to unify AI, analytics, and data across cloud and on-premises environments to support governed, production-scale AI agents for large enterprises. We’ll now examine how the launch of the Autonomous...

UFP Industries (UFPI) is back in focus after reporting a year over year drop in first quarter 2026 sales and profit, as softer demand across retail, packaging and construction weighs on investor sentiment. See our latest analysis for UFP Industries. The share price has been under pressure, with a 90 day share price return of 26.56% decline and a 1 year total shareholder return of 13.59% decline. This signals fading momentum, even as acquisitions and buybacks continue in an effort to reshape...